Aims to Raise Capital to Fund Global Clinical Studies for LNP7457 (PRMT5) & LNP8701 (SOS1) MUMBAI, India and NAPLES, Fla., July 21, 2026 /PRNewswire/ -- Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced the...
Hence then, the article about lupin spins out two oncology programs to kaveri therapeutics to advance its oncology strategy was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Lupin Spins Out Two Oncology Programs to Kaveri Therapeutics to Advance its Oncology Strategy )
Also on site :
- ESMO 2026 .. Mabwell to Present Latest Clinical Data on Nectin-4-targeting ADC 9MW2821 for Triple Negative Breast Cancer in Oral Presentation
- 1928 Beach Legend, Named Among Most 'Historic Hotels of America,' Is Still a Vintage Hotspot Nearly 10 Decades Later
- ‘Heated Rivalry’ Is First TV Series Soundtrack in More Than a Decade to Achieve This Billboard 200 Feat